摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-ethoxy-2-hydrazinopyridine | 1211595-93-5

中文名称
——
中文别名
——
英文名称
6-ethoxy-2-hydrazinopyridine
英文别名
(6-ethoxypyridin-2-yl)hydrazine
6-ethoxy-2-hydrazinopyridine化学式
CAS
1211595-93-5
化学式
C7H11N3O
mdl
——
分子量
153.184
InChiKey
AMACKJNPJPBXEE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    60.2
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonists
    摘要:
    Previously disclosed C6 amido and benzimidazole dihydropyrazolopyrimidines were potent and selective blockers of I-Kur current. Syntheses and SAR for C6 triazolo and imidazo dihydropyrazolopyrimidines series are described. Trifluoromethylcyclohexyl N(1) triazole, compound 51, was identified as a potent and selective K(v)1.5 inhibitor with an acceptable PK and liability profile. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2013.01.064
  • 作为产物:
    描述:
    2-氯-6-乙氧基吡啶一水合肼 作用下, 以 乙醇 为溶剂, 反应 72.0h, 生成 6-ethoxy-2-hydrazinopyridine
    参考文献:
    名称:
    Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonists
    摘要:
    Previously disclosed C6 amido and benzimidazole dihydropyrazolopyrimidines were potent and selective blockers of I-Kur current. Syntheses and SAR for C6 triazolo and imidazo dihydropyrazolopyrimidines series are described. Trifluoromethylcyclohexyl N(1) triazole, compound 51, was identified as a potent and selective K(v)1.5 inhibitor with an acceptable PK and liability profile. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2013.01.064
点击查看最新优质反应信息

文献信息

  • Condensed pyrazole derivatives, process for producing the same and use thereof
    申请人:——
    公开号:US20030187014A1
    公开(公告)日:2003-10-02
    Novel pharmaceutical compositions for inhibiting Th2-selective immune response and pharmaceutical compositions for inhibiting cyclooxygenase comprising condensed pyrazole derivatives represented by the general formula (I): 1 or salts thereof.
    用于抑制Th2选择性免疫应答的新型药物组合物和包括由一般式(I)表示的紧缩吡唑烷衍生物的药物组合物,或其盐。
  • CONDENSED PYRAZOLE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF
    申请人:TAKEDA CHEMICAL INDUSTRIES, LTD.
    公开号:EP1270572A1
    公开(公告)日:2003-01-02
    Novel pharmaceutical compositions for inhibiting Th2-selective immune response and pharmaceutical compositions for inhibiting cyclooxygenase comprising condensed pyrazole derivatives represented by the general formula (I): or salts thereof.
    用于抑制 Th2 选择性免疫反应的新型药物组合物和用于抑制环氧化酶的药物组合物,包含由通式(I)代表的缩合吡唑衍生物: 或其盐类。
  • US6949648B2
    申请人:——
    公开号:US6949648B2
    公开(公告)日:2005-09-27
  • Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonists
    作者:Heather J. Finlay、Ji Jiang、Yolanda Caringal、Alexander Kover、Mary Lee Conder、Dezhi Xing、Paul Levesque、Timothy Harper、Mei Mann Hsueh、Karnail Atwal、Michael Blanar、Ruth Wexler、John Lloyd
    DOI:10.1016/j.bmcl.2013.01.064
    日期:2013.3
    Previously disclosed C6 amido and benzimidazole dihydropyrazolopyrimidines were potent and selective blockers of I-Kur current. Syntheses and SAR for C6 triazolo and imidazo dihydropyrazolopyrimidines series are described. Trifluoromethylcyclohexyl N(1) triazole, compound 51, was identified as a potent and selective K(v)1.5 inhibitor with an acceptable PK and liability profile. (C) 2013 Elsevier Ltd. All rights reserved.
查看更多